fstockfoto / iStockphoto.com
In a much-awaited judgment, the US Supreme Court has confirmed that the Patent Trial and Appeal Board (PTAB) cannot choose to review only some challenged claims in an inter partes review (IPR)—it must assess them all.
If you have already subscribed please login.
If you have any technical issues please email tech support.
US Supreme Court, ComplementSoft, SAS Institute, America Invents Act, inter partes reviews
